BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35139400)

  • 1. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
    Singal AG; Pillai A; Tiro J
    PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.
    Singal AG; Patibandla S; Obi J; Fullington H; Parikh ND; Yopp AC; Marrero JA
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1925-1932.e1. PubMed ID: 32920214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
    Atiq O; Tiro J; Yopp AC; Muffler A; Marrero JA; Parikh ND; Murphy C; McCallister K; Singal AG
    Hepatology; 2017 Apr; 65(4):1196-1205. PubMed ID: 27775821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.
    Choi DT; Kum HC; Park S; Ohsfeldt RL; Shen Y; Parikh ND; Singal AG
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):976-987.e4. PubMed ID: 30616961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
    Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Cano A; Gonzales M; Ransom C; Jaurez E; Carranza O; Quirk L; Morgan T; Gopal P; Patel MS; Lieber S; Louissaint J; Cotter TG; VanWagner LB; Yang JD; Parikh ND; Yopp A; Rich NE; Singal AG
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):295-304.e2. PubMed ID: 37573986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
    Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
    JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
    Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
    Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.
    Wolf E; Rich NE; Marrero JA; Parikh ND; Singal AG
    Hepatology; 2021 Feb; 73(2):713-725. PubMed ID: 32383272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
    Moon AM; Weiss NS; Beste LA; Su F; Ho SB; Jin GY; Lowy E; Berry K; Ioannou GN
    Gastroenterology; 2018 Oct; 155(4):1128-1139.e6. PubMed ID: 29981779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
    Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Screening for Hepatocellular Carcinoma Effective?
    Lee RM; Russell MC
    Adv Surg; 2023 Sep; 57(1):73-86. PubMed ID: 37536863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project.
    Rogal SS; Taddei TH; Monto A; Yakovchenko V; Patton H; Merante M; Spoutz P; Chia L; Yudkevich J; Aytaman A; Rabiee A; John BV; Blechacz B; Cai CX; Gilles H; Shah AS; McCurdy H; Puri P; Jou J; Mazhar K; Dominitz JA; Anwar J; Morgan TR; Ioannou GN
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):324-338. PubMed ID: 37460005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
    Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
    PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary care for patients with HCC: a systematic review and meta-analysis.
    Seif El Dahan K; Reczek A; Daher D; Rich NE; Yang JD; Hsiehchen D; Zhu H; Patel MS; Bayona Molano MDP; Sanford N; Gopal P; Parikh ND; Yopp AC; Singal AG
    Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37102768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
    Hanouneh IA; Alkhouri N; Singal AG
    Clin Mol Hepatol; 2019 Sep; 25(3):264-269. PubMed ID: 30827081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
    Huang DQ; Tan DJH; Ng CH; Amangurbanova M; Sutter N; Lin Tay PW; Lim WH; Yong JN; Tang A; Syn N; Muthiah MD; Tan EXX; Dave S; Tay B; Majzoub AM; Gerberi D; Kim BK; Loomba R
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1169-1177. PubMed ID: 35940513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.